The use of individualized tumor response testing in treatment selection: second randomization results from the LRF CLL4 trial and the predictive value of the test at trial entry.

E Matutes, A G Bosanquet, R Wade, S M Richards, M Else, D Catovsky

Leukemia 2013 Feb

filter terms:

all
phenotype
tissue
show more »
show less «

No abstract available.

Citation

E Matutes, A G Bosanquet, R Wade, S M Richards, M Else, D Catovsky. The use of individualized tumor response testing in treatment selection: second randomization results from the LRF CLL4 trial and the predictive value of the test at trial entry. Leukemia. 2013 Feb;27(2):507-10

Mesh Tags

Substances

PMID: 22810506

View Full Text

FAQ

The use of individualized tumor response testing in treatment selection: second randomization results from the LRF CLL4 trial and the predictive value of the test at trial entry.

filter terms:

Citation

var meshTagsSectionCollapsed = true; Mesh Tags

var substancesSectionCollapsed = true; Substances

Mesh Tags

Substances